As part of the U.S. Food and Drug Administration’s technology and data modernization effort, the Office of Digital Transformation (ODT) has been established to include…
As part of the U.S. Food and Drug Administration’s technology and data modernization effort, the Office of Digital Transformation (ODT) has been established to include…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
Peer Review Week (PRW) is a yearly event celebrating the essential role of peer review in maintaining scientific quality. From September 20-24th, many of the…
U.S. News and World Report has released its annual best national university rankings with Princeton University leading the way. This latest report evaluates 1,466 U.S….
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
In response to concerns raised by Diplomates and the public regarding COVID-19 disinformation, the American Board of Family Medicine (ABFM), the American Board of Internal…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
Investigators are ultimately responsible for the conduct of a clinical trial per U.S. Food and Drug Administration (FDA) regulations at 21 CFR 56 and per…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The World Health Organization (WHO) has released a draft working document for comments on good manufacturing practices (GMP) for investigational products. They also issued a…
To comply with the ClinicalTrials.gov requirements, responsible parties should submit registration and summary results information for certain applicable clinical trials, as per regulations at 42…